Berkeley Lab has developed a cuff-based technology to monitor both endothelial function and endothelium-independent vasodilation. Studies on human subjects have verified that the cuff-based method is 37% more sensitive to arterial relaxation than brachial artery imaging.
Berkeley Lab supports more than 10,000 jobs in the Bay Area and nearly 20,000 jobs across the country, according to a new economic impact study.
Researchers at Berkeley Lab, in collaboration with Carnegie Mellon University, have developed a new battery material that could enable long-range electric vehicles that can drive for hundreds of miles on a single charge, and eVTOL (electric vertical takeoff and landing) aircraft.
A technology spun from carbon nanotube sensors discovered 20 years ago by Berkeley Lab scientists could one day help health care providers test patients for COVID-19, the disease caused by the coronavirus SARS-CoV-2.
Scientists at Berkeley Lab are studying how an anti-radiation-poisoning pill could also help to protect people from the potential toxicity of gadolinium, a critical ingredient in widely used contrast dyes for MRI scans.
The promise of being able to quickly and accurately screen for diseases or chemical contaminants in a tiny drop of blood has long been an elusive goal. But scientist Daojing Wang says his company’s technology is up to the job.
Scientists used to come to Gregory Kurtzer of Lawrence Berkeley National Laboratory’s IT department a lot, asking for a better way to use software containers in a high-performance computing (HPC) environment. After a while he got tired of saying, “Sorry, not possible.” So he invented a solution and named it Singularity.
The inaugural cohort of innovators—a total of six projects—has attracted more than $10 million in competitive state and federal grants, with 20 percent of that going to their Berkeley Lab collaborators. These projects have also secured more than $5 million in initial private investment.
As often happens in science, what started as a research project to make one thing turned into something completely different. Berkeley Lab researchers Nitash Balsara and Hany Eitouni were developing an electroresponsive polymer that turned out to be not such a good artificial muscle, their original goal, but an excellent basis for a battery electrolyte—so good, in fact, that it was recently acquired by a major multinational company.
It’s no secret that extremophiles, or microbes that live in places like polar glaciers and toxic waste pools, may hold treasures worth billions. Now basic biology research has led to the formation of CinderBio, a startup co-founded by Berkeley Lab scientists Steve Yannone and Jill Fuss that produces heat- and acid-stable enzymes.